Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Though no evidence of this has appeared in published trials
A combined approach should be guided by a healthcare professional and monitored with appropriate labs
Key characteristics A small molecule (quinolinium derivative), NOT a peptide Acts as an inhibitor of the enzyme NNMT Rationale is preservation of NAD+ / methyl-donor balance in metabolically active tissue Evidence to date is largely preclinical (cell and rodent models) No approved human therapeutic indication Reported research dosing reference only Educational reference, not dosing guidance
The pharmacist will explain what is appropriate for your circumstances
The primary practical advantage of the blend format is compliance and consistency: a single reconstitution ensures both peptides are delivered in the intended ratio at every administration, eliminating the variability that arises from drawing from two separate vials
In theory, the two address different stages of the same biological process
US$ 29.34
US$ 28.77
US$ 23.05
US$ 20.11
US$ 25.00
US$ 28.24
